Golimumab in unresponsive ulcerative colitis
Elisabeth Lippert, Martina Müller, Claudia Ott University Hospital Regensburg, Department of Internal Medicine I, Regensburg, Germany Abstract: Ulcerative colitis (UC) is a chronic inflammation mainly affecting the colon mucosa. It predominantly occurs in younger patients. Until recently,...
Guardado en:
Autores principales: | Lippert E, Müller M, Ott C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/450141bee2da4170ac657202e4618544 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Infliximab in ulcerative colitis
por: Avi Levin, et al.
Publicado: (2008) -
The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis
por: Heslinga SC, et al.
Publicado: (2018) -
Pediatric ulcerative colitis: current treatment approaches including role of infliximab
por: Bradley GM, et al.
Publicado: (2012) -
New and emerging treatments for ulcerative colitis: a focus on vedolizumab
por: Gledhill T, et al.
Publicado: (2013) -
ASSESSMENT OF SEVERITY OF ULCERATIVE COLITIS ON FIRST COLONOSCOPIC EXAMINATION
por: Rabia Tariq, et al.
Publicado: (2021)